NCT02460237
- Conditions
- Cervical Carcinoma, Communicable Diseases, DNA Virus Infections, +23 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Clinical trial condition
Papillomavirus Infections
Explore clinical trials studying Papillomavirus Infections. Study availability and eligibility vary by location and protocol.
438 public trials
64 recruiting studies
Papillomavirus Infections trial results
NCT03372395
- Conditions
- ASC-US, Atypical Squamous Cells of the Cervix, Bacterial Infections and Mycoses, +31 more
- Locations
-
Not specified
Completed
Phase I of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation for CIN 2 or 3
NCT00685412
- Conditions
- Communicable Diseases, DNA Virus Infections, Disease Attributes, +21 more
- Locations
-
- Lyndhurst Gynecologic Associates Winston-Salem, North Carolina, United States
- Laurel Highlands, OB/GYN, P.C. Hopwood, Pennsylvania, United States
- University of Pennsylvania Philadelphia, Pennsylvania, United States
- Clinical Research Puerto Rico San Juan, Puerto Rico
NCT02139267
- Conditions
- Cervical Intraepithelial Neoplasia, Communicable Diseases, DNA Virus Infections, +19 more
- Locations
-
- Keimyung University Dongsan Medical Center Daegu, South Korea
- Cheil General Hospital & Women's Healthcare Center Seoul, South Korea
- The Catholic University of Korea Seoul St.Mary's Hospital Seoul, South Korea
- Korea University Guro Hospital Seoul, South Korea
NCT01078220
- Conditions
- Communicable Diseases, DNA Virus Infections, Disease Attributes, +11 more
- Locations
-
Not specified
NCT01265212
- Conditions
- Communicable Diseases, DNA Virus Infections, Disease Attributes, +11 more
- Locations
-
- Sanford Health Sioux Falls, South Dakota, United States
NCT02714114
- Conditions
- Communicable Diseases, DNA Virus Infections, Disease Attributes, +11 more
- Locations
-
- Pierre Van Damme Wilrijk, Antwerp, Belgium
NCT00478621
- Conditions
- Communicable Diseases, DNA Virus Infections, Disease Attributes, +11 more
- Locations
-
- GSK Investigational Site Brussels, Belgium
- GSK Investigational Site Ghent, Belgium
- GSK Investigational Site Wilrijk, Belgium
Completed
A Trial of the Efficacy and Safety of Topical Nitric Oxide in Patients With Anogenital Warts
NCT02015260
- Conditions
- Anogenital Warts, Communicable Diseases, Condylomata Acuminata, +17 more
- Locations
-
Not specified
NCT00090220
- Conditions
- Communicable Diseases, DNA Virus Infections, Disease Attributes, +14 more
- Locations
-
Not specified